Dupuytren's Disease: Review of the Current Literature.
作者信息
Khashan Morsi, Smitham Peter J, Khan Wasim S, Goddard Nicholas J
机构信息
Orthopedic Surgery Department, Tel-Aviv Soursky Medical Center, Tel-Aviv, Israel.
出版信息
Open Orthop J. 2011;5 Suppl 2:283-8. doi: 10.2174/1874325001105010283. Epub 2011 Jul 28.
Abstract
Dupuytren's disease is one of the most common condition seen by hand surgeons. It is not only prevalent but can also be a most debilitating condition resulting in significant loss of function of the fingers involved. The cause of this disease, however still remains largely unknown although some recent evidence suggests a stem cell etiology. This review article summarizes the current known knowledge of Dupuytren's as well as the clinical findings, investigations and treatments available.
摘要
相似文献
1
Dupuytren's Disease: Review of the Current Literature.
Open Orthop J. 2011;5 Suppl 2:283-8. doi: 10.2174/1874325001105010283. Epub 2011 Jul 28.
2
A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (HAND-1): study protocol for a randomised controlled trial.一项关于针状筋膜切开术与有限筋膜切除术治疗手指掌腱膜挛缩症的多中心随机对照试验的可接受性和设计的可行性研究（HAND-1）：一项随机对照试验的研究方案
Trials. 2017 Aug 25;18(1):392. doi: 10.1186/s13063-017-2127-9.
4
Repeat limited fasciectomy is a safe and effective treatment for recurrence of Dupuytren's disease.重复有限筋膜切开术是治疗 Dupuytren 病复发的一种安全有效的方法。
Bone Joint J. 2021 May;103-B(5):946-950. doi: 10.1302/0301-620X.103B5.BJJ-2020-1393.R2.
5
Dupuytren's interventions surgery versus collagenase (DISC) trial: study protocol for a pragmatic, two-arm parallel-group, non-inferiority randomised controlled trial.# 标题：迪普伊特伦氏干预手术与胶原酶（DISC）试验：一项实用、双臂平行组、非劣效性随机对照试验的研究方案。
# 译文解析：
- 标题中的“Dupuytren's”和“DISC”是医学专有名词，分别是迪普伊特伦氏病和胶原酶的缩写，可直接保留英文；
- “interventions surgery”和“collagenase”是“迪普伊特伦氏干预手术”和“胶原酶”的英文表达，在标题中为常见医学缩写，可直接保留英文；
- “versus”是英文词汇，可直接保留；
- “protocol”是“方案”的意思，可保留英文；
- “pragmatic”是“实用的”的意思，“parallel-group”是“平行组”的意思，“non-inferiority”是“非劣效性”的意思，“randomised controlled trial”是“随机对照试验”的意思，均为医学专业词汇，可保留英文。
Trials. 2021 Sep 30;22(1):671. doi: 10.1186/s13063-021-05595-w.
6
Results of surgical treatment of Dupuytren's disease in women: a review of 109 consecutive patients.女性掌腱膜挛缩症的外科治疗结果：109例连续患者的回顾
J Hand Surg Am. 2007 Nov;32(9):1423-8. doi: 10.1016/j.jhsa.2007.06.015.
7
The Surgical Release of Dupuytren's Contracture Using Multiple Transverse Incisions.采用多个横向切口手术松解掌腱膜挛缩症
Arch Plast Surg. 2012 Jul;39(4):426-30. doi: 10.5999/aps.2012.39.4.426. Epub 2012 Jul 13.
8
A single-centre cost comparison analysis of collagenase injection versus surgical fasciectomy for Dupuytren's contracture of the hand.手部挛缩性杜普伊特伦氏病中胶原酶注射与手术筋膜切开术的单中心成本比较分析。
J Plast Reconstr Aesthet Surg. 2014 Mar;67(3):368-72. doi: 10.1016/j.bjps.2013.12.030. Epub 2014 Jan 4.
9
Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.澳大利亚医疗体系中溶组织梭状芽孢杆菌胶原酶与筋膜切除术治疗掌腱膜挛缩症的成本比较
J Hand Surg Asian Pac Vol. 2018 Sep;23(3):336-341. doi: 10.1142/S2424835518500327.
10
Dupuytren's Contracture: An Evidence Based Review.掌腱膜挛缩症：基于证据的综述
Ann Plast Surg. 2018 Dec;81(6S Suppl 1):S97-S101. doi: 10.1097/SAP.0000000000001607.
引用本文的文献
1
Molecular genetics of Dupuytren's contracture.掌腱膜挛缩症的分子遗传学
EFORT Open Rev. 2024 Aug 1;9(8):723-732. doi: 10.1530/EOR-23-0056.
2
Comparing Complications and Patient Satisfaction Following Injectable Collagenase Versus Limited Fasciectomy for Dupuytren's Disease: A Systematic Review and Meta-Analysis.注射用胶原酶与局限性掌腱膜切除术治疗掌腱膜挛缩症的并发症及患者满意度比较：一项系统评价和荟萃分析
Cureus. 2024 Jan 29;16(1):e53147. doi: 10.7759/cureus.53147. eCollection 2024 Jan.
3
Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease.纳米颗粒介导的SFRP4小干扰RNA递送用于治疗掌腱膜挛缩症的效果
Gene Ther. 2023 Feb;30(1-2):31-40. doi: 10.1038/s41434-022-00330-9. Epub 2022 Mar 28.
4
Dupuytren's Disease: An Outcomes-Focused Update.掌腱膜挛缩症：以结果为导向的最新进展
Semin Plast Surg. 2021 Aug;35(3):216-222. doi: 10.1055/s-0041-1731631. Epub 2021 Jul 6.
5
Double Spiral Dupuytren's Disease: Case of Ulnar and Radial Spiral Cords in Shared Digit.双螺旋掌腱膜挛缩症：累及同一手指的尺侧和桡侧螺旋索带病例
Plast Reconstr Surg Glob Open. 2020 Oct 28;8(10):e3212. doi: 10.1097/GOX.0000000000003212. eCollection 2020 Oct.
6
Cost-effectiveness of Recurrent Dupuytren Contracture Treatment.复发性掌腱膜挛缩治疗的成本效益。
JAMA Netw Open. 2020 Oct 1;3(10):e2019861. doi: 10.1001/jamanetworkopen.2020.19861.
7
Surgical treatment results for dupuytren's disease.掌腱膜挛缩症的手术治疗结果。
Acta Ortop Bras. 2017 May-Jun;25(3):71-73. doi: 10.1590/1413-785220172503164827.
8
The "Bowstring Arch Bridge" Analogy to Guide Sequential Portal Placement during Needle Aponeurotomy in the Treatment of Dupuytren Contracture.“弓弦拱桥”类比法指导治疗掌腱膜挛缩症时针刀腱膜切开术中的序贯门脉放置
J Hand Microsurg. 2016 Dec;8(3):185-186. doi: 10.1055/s-0036-1593391. Epub 2016 Sep 23.
9
Sonographic Findings of Common Musculoskeletal Diseases in Patients with Diabetes Mellitus.糖尿病患者常见肌肉骨骼疾病的超声检查结果
Korean J Radiol. 2016 Mar-Apr;17(2):245-54. doi: 10.3348/kjr.2016.17.2.245. Epub 2016 Mar 2.
10
Epidemiological profile of Dupuytren's disease in Taiwan (Ethnic Chinese): a nationwide population-based study.台湾地区（华裔）掌腱膜挛缩症的流行病学概况：一项基于全国人口的研究。
BMC Musculoskelet Disord. 2015 Feb 10;16:20. doi: 10.1186/s12891-015-0476-7.
本文引用的文献
1
Characterization of stem cells in Dupuytren's disease.对杜普伊特伦病中干细胞的特征进行描述。
Br J Surg. 2011 Feb;98(2):308-15. doi: 10.1002/bjs.7307.
2
IDENTICAL DUPUYTREN'S CONTRACTURE IN IDENTICAL TWINS.同卵双胞胎中的相同掌腱膜挛缩症
Can Med Assoc J. 1938 Sep;39(3):225-6.
3
4
Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years.早期杜普伊特伦挛缩的放射治疗。13 年后的长期结果。
Strahlenther Onkol. 2010 Feb;186(2):82-90. doi: 10.1007/s00066-010-2063-z. Epub 2010 Jan 28.
5
Dupuytren's disease: a predominant reason for elective finger amputation in adults.
Acta Chir Belg. 2009 Jul-Aug;109(4):494-7. doi: 10.1080/00015458.2009.11680467.
6
The role of an MMP inhibitor in the regulation of mechanical tension by Dupuytren's disease fibroblasts.基质金属蛋白酶抑制剂在掌腱膜挛缩症成纤维细胞调节机械张力中的作用
J Hand Surg Eur Vol. 2009 Dec;34(6):783-7. doi: 10.1177/1753193409345188. Epub 2009 Sep 28.
7
Injectable collagenase clostridium histolyticum for Dupuytren's contracture.注射用溶组织梭菌胶原酶治疗掌腱膜挛缩症
N Engl J Med. 2009 Sep 3;361(10):968-79. doi: 10.1056/NEJMoa0810866.
8
Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.骨膜蛋白可差异诱导原发性掌腱膜挛缩症及相邻掌侧筋膜细胞的增殖、收缩和凋亡。
Exp Cell Res. 2009 Dec 10;315(20):3574-86. doi: 10.1016/j.yexcr.2009.07.015. Epub 2009 Jul 18.
9
Nonoperative treatment of Dupuytren's disease.掌腱膜挛缩症的非手术治疗
J Hand Surg Am. 2008 Sep;33(7):1208-10. doi: 10.1016/j.jhsa.2008.05.027.
10
Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.基质金属蛋白酶及其抑制剂在杜普伊特伦氏挛缩症患者的 cords 和 nodules 中的表达。
Arch Orthop Trauma Surg. 2009 Nov;129(11):1453-9. doi: 10.1007/s00402-008-0726-3. Epub 2008 Aug 30.
Zotero 插件